Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.3545
S.3545: Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Coronavirus Patients Act of 2020
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced March 19, 2020
- Latest Major Action March 19, 2020
- See the four similar bills introduced in other congresses.
Bill Sponsor
Bill Version
- Introduced in Senate - March 19, 2020
Bill Summary
Reciprocity Ensures Streamlined Use of Lifesaving Treatments for Coronavirus Patients Act of 2020 This bill establishes a reciprocal marketing approval process that allows for the sale of a drug, biological product, or medical device that has not been approved by the Food and Drug Administration (FDA) if the product is approved for sale in another country for the treatment or prevention of COVID-19 (i.e., coronavirus disease 2019) and there is...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
March 19, 2020 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
March 19, 2020 |
Introduced in the Senate by Ted Cruz (R-Texas) |